Global Regenerative Medicine for Cartilage Market Size study & Forecast, by Type (Cell-based, Non-cell-based) By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Ribrous Cartilage Repair and Regeneration)

Global Regenerative Medicine for Cartilage Market Size study & Forecast, by Type (Cell-based, Non-cell-based) By Application (Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Ribrous Cartilage Repair and Regeneration) and Regional Analysis, 2023-2030

Global Regenerative Medicine for Cartilage Market is valued at approximately USD xx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xx% over during the forecast period 2023-2030. Regenerative Medicine for Cartilage refers to a branch of medical science and therapeutic approaches aimed at repairing, replacing, or regenerating damaged or degenerated cartilage tissue within the human body. Cartilage is a specialized connective tissue that cushions and supports joints, providing a smooth surface for frictionless movement. The Regenerative Medicine for Cartilage market Market is expanding because of factors such as the increasing prevalence of Sports and recreational injuries and the growing number of geriatric populations. Regenerative medicine techniques for cartilage involve the use of biological materials, cells, or tissue engineering to stimulate the body's natural healing processes and restore or replace damaged cartilage. As a result, the demand of for Regenerative Medicine for Cartilage has progressively increased in the international market during the forecast period 2023-2030.

Athletes and individuals engaged in sports or recreational activities are often motivated to seek advanced and efficient treatment options to recover quickly and resume their activities. Regenerative medicine offers promising alternatives to traditional treatments, providing the potential for enhanced and accelerated healing. According to The National Safety Council Organization, the global number of sports and recreational injuries has increased 20% in 2021 and reached up to 12% in 2022. Furthermore, in 2022 there are about 445,642 injuries report reported due to sports and recreational activities compared to 409,224 injuries in 2021, the age group with the highest injury rate is 15- to 24-year-olds. Another important factor that drives the Regenerative Medicine for Cartilage market Market is the increasing number of geriatric populations. The elderly population tends to prioritize treatments that offer long-term benefits and reduce the need for frequent interventions. Regenerative medicine approaches aim at promoting tissue regeneration and repairing cartilage, addressing the root cause, and potentially providing longer-lasting relief. In addition, as per World Health Organization indicates that the global population aged 60 and above is expected to double to around 2.1 billion by 2050. Moreover, those aged 80 and beyond are anticipated to triple between 2020 and 2050, reaching a staggering 426 million. Moreover, technological advancements associated to with cartilage restoration technologies and growing investments in R&D related to cartilage restoration regenerative medicine is are anticipated to create a lucrative growth opportunity opportunities for the market over the forecast period. However, the increasing prevalence of sports and recreational injuries and the growing number of geriatric populations is are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Regenerative Medicine for Cartilage Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Europe dominated the market in 2022 owing to the rising number of professional sports and recreational active participants in the region. Professional athletes and active individuals are more susceptible to cartilage injuries due to the repetitive stress and impact associated with sports and physical activities. The higher prevalence of cartilage damage fuels the need for regenerative medicine solutions to address these specific issues. The region’s dominant performance is anticipated to propel the overall demand of for Regenerative Medicine for Cartilage. Furthermore, Asia Pacific is expected to grow fastest during over the forecast period, owing to factors such as increasing healthcare expenditure in the region. Higher healthcare expenditure allows governments, private institutions, and pharmaceutical companies to allocate more funds to research and development in regenerative medicine. This investment fosters innovation, leading to the development of advanced therapies for cartilage repair.

Major market player included in this report are:
B. Braun Melsungen AG
Zimmer Biomet Holdings Inc.
Vericel Corporation
Stryker Corporation
Smith & Nephew plc
Arthrex Inc.
CONMED Corporation
Collagen Solutions PLC
BioTissue Technologies GmbH
Sartorius CellGenix GmbH

Recent Developments in the Market:
 In May 2022, Ocugen, IncInc., a biotechnology company has introduced NeoCart, a Phase 3 cell therapy platform technology designed to address full-thickness lesions of the knee cartilage in adults. It is a three-dimensional tissue-engineered disc of fresh cartilage produced by cultivating chondrocytes, the cells responsible for cartilage maintenance, derived from the patient on a distinctive scaffold. This innovative therapy holds the potential to expedite healing and alleviate pain by reconstructing damaged knee cartilage. NeoCart targets the root cause of pain, restoring a patient's knee joint surface to a similar functional state as before the injury. The overarching objective is to impede the progression to osteoarthritis, offering a promising solution for patients with knee cartilage issues.

Global Regenerative Medicine for Cartilage Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered – Type, Application, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type
Cell-based
Non-cell-based

By Application
Hyaline Cartilage Repair and Regeneration
Elastic Cartilage Repair and Regeneration
Ribrous Cartilage Repair and Regeneration

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.